The 5th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 6th - 7th February 2020 in San Diego, CA would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics areas. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.
This two-day event will invite 200+ biomarker discovery professionals, 30+ expert speakers and 15+ solution/technology providers to a unique platform to deliver niche buyer-seller ecosystem in the biomarker Industry.
Investigator, Biomarker Expert, Novartis
Senior Director, Clinical Pharmacology and Translational Medicine, Eisai
Professor of Neurology, University of California
Geography Head-US, MarketsandMarkets
Vice President, Head, Translational Medicine, , Syncopation Lifesciences
Biomarker Clinical Assay Lead, Pfizer
Senior Medical Director , Viracta Therapeutics, Inc.
Executive Director, Precision Medicine Leader, Novartis
Co-Investigator, Fred Hutch
Director, Consulting Services, IDDI
Director, Program for Neuroproteomics and Biomarkers Research, University of Florida
Chief Technology Officer, Boundless Bio
CEO , Eutropics Pharmaceuticals Inc.
Executive Director , Crown Bioscience
Co-Founder, Attivare Therapeutics
Vice President, Scientific Collaborations , HTG Molecular Diagnostics
Director, Head of RWE & Molecular Disease Characterization, Experimental Medicine Unit, GSK
Chief Commercial Officer, Tempus
Chief Medical Officer , Dermtech
R&D Director, Companion Diagnostics, Agilent
Principal Investigator, Navigate BioPharma
Vice President, Clinical Development & Medical Affairs, Biodesix
Vice President, Commercial Operations, Sysmex Inostics
CSO & CEO, Invivoscribe
Business Development Manager, Leica Biosystems
Senior Director, Clinical Biomarkers, Poseida Therapeutics
Executive Director and Head of CDx & Lab Operations, Precision Medicine, Regeneron Pharmaceuticals
Head, IVD Strategy and Development, Amgen
Senior Director, Business Development, Pharma & Biotech, Imagia
Program Director, Biorepositories and Biospecimen Research Branch (BBRB), , NIH
Sheraton San Diego Hotel & Marina, 1380 Harbor Island Dr, CA 92101, United States